Klinikum der Universität München Großhadern

Würzburg, Bavaria 97080

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Mantle-Cell, Medullary Thyroid Cancer

Studies at this site

• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
• A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer — Running, not enrolling